Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants

Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants

Abstract Due to the continuously mutating nature of the H3N2 virus, two aspects were considered when preparing the H3N2 microneedle vaccines: (1) rapid preparation and (2) cross-protection against multiple antigenic variants. Previous methods of measuring hemagglutinin (HA) content required the stan...

Full description

Bibliographic Details
Main Authors: Yura Shin, Jeonghun Kim, Jong Hyeon Seok, Heedo Park, Hye-Ran Cha, Si Hwan Ko, Jae Myun Lee, Man-Seong Park, Jung-Hwan Park
Format: Article
Language:English
Published: Nature Portfolio 2022-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-16365-2

Internet

https://doi.org/10.1038/s41598-022-16365-2

Similar Items